Mabcure Stock Analysis
| MBCI Stock | USD 0.0001 0.00 0.00% |
MabCure is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of MabCure pink sheet analysis is to determine its intrinsic value, which is an estimate of what MabCure is worth, separate from its market price. There are two main types of MabCure's stock analysis: fundamental analysis and technical analysis.
The MabCure pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MabCure's ongoing operational relationships across important fundamental and technical indicators.
MabCure |
MabCure Pink Sheet Analysis Notes
The company has price-to-book ratio of 0.06. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MabCure recorded a loss per share of 0.19. The entity had not issued any dividends in recent years. The firm had 20:1 split on the 26th of November 2007. MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. MabCure Inc. was founded in 2006 and is based in White Plains, New York. Mabcure is traded on OTC Exchange in the United States.The quote for MabCure is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about MabCure contact the company at 845 591 3144 or learn more at http://www.mabcure.com.MabCure Investment Alerts
| MabCure generated a negative expected return over the last 90 days | |
| MabCure has some characteristics of a very speculative penny stock | |
| MabCure has a very high chance of going through financial distress in the upcoming years | |
| MabCure currently holds 304.98 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. MabCure has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist MabCure until it has trouble settling it off, either with new capital or with free cash flow. So, MabCure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MabCure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MabCure to invest in growth at high rates of return. When we think about MabCure's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 500 K. Net Loss for the year was (12.26 M) with profit before overhead, payroll, taxes, and interest of 500 K. | |
| MabCure currently holds about 146.44 K in cash with (61.39 K) of positive cash flow from operations. |
MabCure Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 643.64 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MabCure's market, we take the total number of its shares issued and multiply it by MabCure's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MabCure, as well as the relationship between them.MabCure Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MabCure middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MabCure. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About MabCure Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how MabCure prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MabCure shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as MabCure. By using and applying MabCure Pink Sheet analysis, traders can create a robust methodology for identifying MabCure entry and exit points for their positions.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. MabCure Inc. was founded in 2006 and is based in White Plains, New York. Mabcure is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding MabCure to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Complementary Tools for MabCure Pink Sheet analysis
When running MabCure's price analysis, check to measure MabCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MabCure is operating at the current time. Most of MabCure's value examination focuses on studying past and present price action to predict the probability of MabCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MabCure's price. Additionally, you may evaluate how the addition of MabCure to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |